HOUSTON, May 1 /PRNewswire-FirstCall/ -- Encysive Pharmaceuticals will hold an investor conference call on Wednesday, May 10, 2006 at 8:00 a.m. ET to discuss its first quarter 2006 financial results.
You may access the call either through the call-in number below or through the audio webcast. The access number for the call is:
Number: (612) 332-1025
Passcode: Encysive Pharmaceuticals
This call is being webcast and can be accessed via Encysive’s web site at http://www.encysive.com .
A replay of the webcast will be available on the Company’s web site through June 10, 2006. Additionally, a replay of the call will be available until Sunday, May 14, 2006 at 11:59 p.m. ET. The call replay can be accessed by calling:
Number: (320) 365-3844 Access Code: 828094 About Encysive Pharmaceuticals
Encysive Pharmaceuticals Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs. Our research and development programs are predominantly focused on the treatment and prevention of interrelated diseases of the vascular endothelium and exploit our expertise in the area of the intravascular inflammatory process, referred to as the inflammatory cascade, and vascular diseases. To learn more about Encysive Pharmaceuticals please visit our web site: http://www.encysive.com .
Encysive Pharmaceuticals Inc.
CONTACT: investors, Ann Tanabe of Encysive Pharmaceuticals Inc.,+1-713-796-8822; or Marcy Strickler of The Trout Group, +1-212-477-9007ext. 27; or media, Dan Budwick of BMC Communications, +1-212-477-9007 ext.14, both for Encysive Pharmaceuticals Inc.
Web site: http://www.encysive.com/
